Biomerica (NASDAQ:BMRA) Issues Earnings Results

Biomerica (NASDAQ:BMRA) posted its earnings results on Tuesday. The company reported ($0.06) earnings per share for the quarter, Zacks reports. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

Biomerica Price Performance

Biomerica stock traded up $0.01 during midday trading on Tuesday, hitting $0.33. The company’s stock had a trading volume of 115,344 shares, compared to its average volume of 259,193. The company has a market cap of $5.51 million, a price-to-earnings ratio of -0.89 and a beta of -1.04. Biomerica has a 1-year low of $0.24 and a 1-year high of $1.35. The company has a 50-day moving average price of $0.33 and a two-hundred day moving average price of $0.34.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.